YCW21· Other

Trestle Biotherapeutics

Bioengineered kidneys for patients with kidney failure

ActiveChecked 24h ago

Batch: W21
Status, per YC: Active
Team size: 2
HQ: San Diego, CA

In W21336 companies, 30% AI

trestlebio.com YC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

Competitors

Closest in what they build, same category.

VolumetricW20Volumetric builds living multicellular tissues with a focus on the…Shared: biotechAcquired

Adjacent

Overlapping tags, a different niche.

Also from W21

Batchmates in Winter 2021.

About Trestle Biotherapeutics

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

San Diego, CA, USA

Biotech

Trestle Biotherapeutics: questions

Which YC batch was Trestle Biotherapeutics in?

Trestle Biotherapeutics was in Y Combinator's Winter 2021 batch (W21).

Is Trestle Biotherapeutics still active?

Y Combinator lists Trestle Biotherapeutics as active.

Where is Trestle Biotherapeutics based?

Trestle Biotherapeutics lists San Diego, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.